关于PEO和PEO-PPG功能化色素纳米颗粒用于药物输送的结构和分子特性
Rejeena Jha1, Hyrum Harlow1, Mourad Benamara2
1Department of Physics, Astronomy, and Materials Science, Missouri State University, Springfield, MO 65804, USA.
Bioengineering (Basel, Switzerland)
|April 27, 2024
概括
基托纳米颗粒 (CS-NP) 在纳米医学中显示出潜力. 将CS-NP与PEO-PPG功能化显著增加了它们的结晶性,影响了它们在药物输送应用中的性能.
科学领域:
- 材料科学 材料科学 材料科学
- 纳米技术纳米技术
- 生物医学工程 生物医学工程
背景情况:
- 素纳米颗粒 (CS-NP) 是多功能纳米载体,用于各种纳米医学应用.
- 了解CS-NP的结构和形态特性对于优化其药物递送能力至关重要.
研究的目的:
- 通过离子凝合成的素纳米粒子 (CS-NP) 的结构,形态和分子特征的研究.
- 评估用聚乙烯氧化物 (PEO) 和PEO-聚乙烯甘醇 (PPG) 功能化对药物输送中CS-NP特性的影响.
主要方法:
- 在不同度 (0.251.0% w/v) 中使用离子凝合成CS-NP.
- 使用PEO和PEO-PPG双块共聚合物的1.0% w/v CS-NP的功能化.
- 使用传输电子显微镜 (TEM),X射线衍射 (XRD) 和富里埃变换红外光谱 (FTIR) 的表征.
主要成果:
- TEM成像揭示了CS-NP,其平均尺寸范围为11.314.8 nm.
- XRD和TEM表示半晶体结构,晶体性受到功能化的影响.
- PEO-PPG功能化显著增加了CS-NP晶度,而PEO单独没有影响. CS/TPP比率没有影响结晶度.
- FTIR证实了TPP的结合和在更晶体的CS-NP中增加的结合.
结论:
- 该研究阐明了合成的CS-NP的结构和形态特性.
- 与PEO-PPG的功能化增强了CS-NP的结晶性,为量身定制的药物递送系统提供了潜力.
- 这些发现有助于合理设计生物医学应用的基托基纳米载体.
相关概念视频
Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...


